Generative Chemistry at Federation Scale

Most pharmaceutical companies have one or two chemistry teams. The CureForge federation has one — but that one team supports every disease vertical, every therapeutic program, every novel-molecule pipeline across the entire research organization. The Drug Discovery Acceleration Institute is the federation’s shared chemistry tier. Ten specialized AI systems collaborate across generative-chemistry pipelines, structure prediction at the resolution of contemporary deep-learning proteinmodeling, protein-protein interface design, absorption-distribution-metabolismexcretion-toxicity prediction, druggability scoring, synthesis-route planning, patentlandscape analysis, and adversarial chemistry review. Wet-lab validation routes through the federation’s physical-world integration layer, ensuring every novel molecule entering federation pipelines has been functionally validated in real biology before deployment. The institute does not work in isolation — it is the chemistry foundation under every other institute that needs novel molecules.

Value proposition:

• Generative chemistry as a federation-wide shared service
• Wet-lab functional validation on every novel molecule entering pipelines
• Adversarial chemistry review on every claim before publication